The TNF Receptor Superfamily in Co-stimulating and Co-inhibitory Responses

Ward-Kavanagh, Lindsay K., Lin, Wai Wai, Šedý, John R., Ware, Carl F.·2016·Immunity
DOI 10.1016/j.immuni.2016.04.019

Cites (225)

Items 201–225 of 225

  1. Changes of soluble CD26 and CD30 levels correlate with response to interferon plus ribavirin therapy in patients with chronic hepatitis C
    Sheng‐Shun Yang, Lin‐Shien Fu, Chi‐Sen Chang · 2006 · Journal of Gastroenterology and Hepatology
  2. Triggering of neoplastic B cells via surface IgM and the cell surface antigens CD20 and CDw40. Responses differ from normal blood B cells and are restricted to certain morphologic subsets
    Klaus Beiske, Edward A. Clark, Harald Holte · 1988 · International Journal of Cancer
  3. Elevated plasma levels of TL1A in newly diagnosed systemic lupus erythematosus patients
    Wang‐Dong Xu, Daojun Chen, Rui Li · 2015 · Rheumatology International
  4. STAT3 Signaling Is Required for Optimal Regression of Large Established Tumors in Mice Treated with Anti-OX40 and TGFβ Receptor Blockade
    Todd Triplett, Christopher Tucker, Kendra Triplett, Zefora Alderman, Lihong Sun, Leona E. Ling, Emmanuel T. Akporiaye, Andrew D. Weinberg · 2015 · Cancer Immunology Research
  5. Impact of exome sequencing in inflammatory bowel disease
    Christopher J. Cardinale · 2013 · World Journal of Gastroenterology
  6. Polymorphic Variants of LIGHT (TNF Superfamily-14) Alter Receptor Avidity and Bioavailability
    Timothy C. Cheung, Ken T. Coppieters, Hideki Sanjo · 2010 · The Journal of Immunology
  7. Host CD25+CD4+Foxp3+ Regulatory T Cells Primed by anti-CD137 mAbs Inhibit Graft-versus-Host Disease
    Juyang Kim, Wongyoung Kim, Hyun Jong Kim et al. · 2011 · Transplantation and Cellular Therapy
  8. Pre‐transplant level of soluble CD30 is associated with infection after heart transplantation
    Afzal Nikaein, Camelia Spiridon, Judson M. Hunt · 2007 · Clinical Transplantation
  9. CD30 Is Required for Activation of a Unique Subset of Interleukin-17A-Producing γδ T Cells in Innate Immunity against Mycobacterium bovis Bacillus Calmette-Guérin Infection
    Ying Jia Guo, Xun Sun, Kensuke Shibata, Hisakata Yamada, Hiromi Muta, Eckhard R. Podack, Yasunobu Yoshikai · 2013 · Infection and Immunity
  10. OX40 controls effector CD4+ T‐cell expansion, not follicular T helper cell generation in acute Listeria infection
    Clare L. Marriott, Emma C. Mackley, Cristina Ferreira, Marc Veldhoen, Hideo Yagita∥, David R. Withers · 2014 · European Journal of Immunology
  11. TL1A/DR3 axis involvement in the inflammatory cytokine network during pulmonary sarcoidosis
    Monica Facco, Anna Cabrelle, Fiorella Calabrese et al. · 2015 · Clinical and Molecular Allergy
  12. The DARC conspiracy – virus invasion tactics
    April Kinkade, Carl F. Ware · 2006 · Trends in Immunology
  13. Evaluation of Soluble CD30 as an Immunologic Marker in Heart Transplant Recipients
    Camelia Spiridon, Judson M. Hunt, Michael J. Mack · 2006 · Transplantation Proceedings
  14. Soluble CD26/CD30 levels in visceral leishmaniasis: markers of disease activity
    Soheila Ajdary, Farhad Riazi‐Rad, Reza Jafari-Shakib · 2006 · Clinical & Experimental Immunology
  15. Anti-OX40L monoclonal antibody prolongs secondary heart allograft survival based on CD40/CD40L and LFA-1/ICAM-1 blockade
    Helong Dai, Fenghua Peng, Minjie Lin et al. · 2015 · Transplant Immunology
  16. Post-transplant soluble CD30 levels are associated with early subclinical rejection in kidney transplantation
    Patricia Cristina Grenzi, Érika F. Campos, Helio Tedesco Silva Junior · 2015 · Transplant Immunology
  17. Significant link between sCD30 changes and HIV viremia in patients treated with HAART
    Priscilla Biswas, Alessandro Cozzi‐Lepri, Fanny Delfanti et al. · 2006 · Journal of Medical Virology
  18. TRAF2 recruitment via T61 in CD30 drives NFκB activation and enhances hESC survival and proliferation
    Nilay Y. Thakar, Dmitry A. Ovchinnikov, Marcus Lachlan Hastie · 2015 · Molecular Biology of the Cell
  19. Therapeutic Blockade of LIGHT Interaction With Herpesvirus Entry Mediator and Lymphotoxin β Receptor Attenuates In Vivo Cytotoxic Allogeneic Responses
    María‐Luisa del Rio, Carlos Fernández‐Renedo, Stefanie Scheu · 2014 · Transplantation
  20. Immune Function Surveillance: Association With Rejection, Infection and Cardiac Allograft Vasculopathy
    Nahla Heikal, Feras M. Bader, Thomas B. Martins et al. · 2012 · Transplantation Proceedings
  21. Innate memory phenotype CD4+ T cells play a role in early protection against infection by Listeria monocytogenes in a CD30L-dependent manner
    Kenji Umeda, Xun Sun, Ying Jia Guo, Hisakata Yamada, Kensuke Shibata, Yasunobu Yoshikai · 2011 · Microbiology and Immunology
  22. Elevated Soluble CD30 Characterizes Patients With Hepatitis C Virus-Induced Liver Allograft Cirrhosis
    Ankit Bharat, Kishore Narayanan, Anjali Golocheikine · 2007 · Transplantation
  23. Post-transplant monitoring of soluble CD30 level as predictor of graft outcome: A single center experience from China
    Dong Wang, Weizhen Wu, Shun-liang Yang · 2012 · Transplant Immunology
  24. Delayed recruitment of lymphocytes into the lungs of CD30-deficient mice during aerogenic Mycobacterium avium infections
    Manuela Flórido, Shaun R. McColl, Rui Appelberg · 2009 · Immunobiology
  25. In Vivo 4-1BB Deficiency in Myeloid Cells Enhances Peripheral T Cell Proliferation by Increasing IL-15
    Beom Kyu Choi, Young H. Kim, Don G. Lee · 2015 · The Journal of Immunology